Gerd Auffarth - 07 Mar 2024 Form 4 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Reporting relationship: Director
Issuer ticker: OTLK
Reported as of: 07 Mar 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Mar 2024, 16:14:48 UTC
Prior SEC filing: 05 Oct 2023
Next SEC filing: 03 Oct 2024
Source filing: View source filing
Reporting owner signature: /s/ Lawrence Kenyon, Attorney-in-Fact

Filing notes and source

Key filing fact

Gerd Auffarth filed Form 4 for Outlook Therapeutics, Inc. (OTLK) on 08 Mar 2024.

Key facts

This page summarizes Gerd Auffarth's Form 4 filing for Outlook Therapeutics, Inc. (OTLK).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Mar 2024, 16:14.

Change

Previous filing in this sequence was filed on 05 Oct 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OTLK transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +94,441
Change %
Price: $0.000000
Shares after: 94,441
Date: 07 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 94,441
Exercise price: $0.4100
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options were granted under the Issuer's 2015 Equity Incentive Plan (the "2015 Plan") and shall fully vest on the earlier of (i) March 7, 2025; or (ii) the date of the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control.